246 related articles for article (PubMed ID: 23410679)
1. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.
Ganesh S; Iyer AK; Morrissey DV; Amiji MM
Biomaterials; 2013 Apr; 34(13):3489-502. PubMed ID: 23410679
[TBL] [Abstract][Full Text] [Related]
2. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
Xia Y; Guo M; Xu T; Li Y; Wang C; Lin Z; Zhao M; Zhu B
Int J Nanomedicine; 2018; 13():1539-1552. PubMed ID: 29588583
[TBL] [Abstract][Full Text] [Related]
3. Self-assembling HA/PEI/dsRNA-p21 ternary complexes for CD44 mediated small active RNA delivery to colorectal cancer.
Feng CL; Han YX; Guo HH; Ma XL; Wang ZQ; Wang LL; Zheng WS; Jiang JD
Drug Deliv; 2017 Nov; 24(1):1537-1548. PubMed ID: 28994324
[TBL] [Abstract][Full Text] [Related]
4. Folate-Mediated Targeted Delivery of siPLK1 by Leucine-Bearing Polyethylenimine.
Hou L; Song Z; Xu Z; Wu Y; Shi W
Int J Nanomedicine; 2020; 15():1397-1408. PubMed ID: 32184594
[TBL] [Abstract][Full Text] [Related]
5. Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.
Yang C; Li C; Zhang P; Wu W; Jiang X
Theranostics; 2017; 7(6):1719-1734. PubMed ID: 28529647
[TBL] [Abstract][Full Text] [Related]
6. Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
Wang K; Kievit FM; Sham JG; Jeon M; Stephen ZR; Bakthavatsalam A; Park JO; Zhang M
Small; 2016 Jan; 12(4):477-87. PubMed ID: 26641029
[TBL] [Abstract][Full Text] [Related]
7. PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery.
Zhao Y; Wang W; Guo S; Wang Y; Miao L; Xiong Y; Huang L
Nat Commun; 2016 Jun; 7():11822. PubMed ID: 27264609
[TBL] [Abstract][Full Text] [Related]
8. Specific cancer stem cell-therapy by albumin nanoparticles functionalized with CD44-mediated targeting.
Li Y; Shi S; Ming Y; Wang L; Li C; Luo M; Li Z; Li B; Chen J
J Nanobiotechnology; 2018 Dec; 16(1):99. PubMed ID: 30501644
[TBL] [Abstract][Full Text] [Related]
9. Near infrared fluorescent nanoparticles based on hyaluronic acid: Self-assembly, optical properties, and cell interaction.
Kelkar SS; Hill TK; Marini FC; Mohs AM
Acta Biomater; 2016 May; 36():112-21. PubMed ID: 26995504
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma.
Logan A; Howard CB; Huda P; Kimpton K; Ma Z; Thurecht KJ; McCarroll JA; Moles E; Kavallaris M
J Control Release; 2024 Mar; 367():806-820. PubMed ID: 38341177
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Macrophage Functional Polarity towards Anti-Inflammatory Phenotype with Plasmid DNA Delivery in CD44 Targeting Hyaluronic Acid Nanoparticles.
Tran TH; Rastogi R; Shelke J; Amiji MM
Sci Rep; 2015 Nov; 5():16632. PubMed ID: 26577684
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance.
Xu Z
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2849-2876. PubMed ID: 37991544
[TBL] [Abstract][Full Text] [Related]
13. Novel polyurethane-based ionene nanoparticles electrostatically stabilized with hyaluronic acid for effective gene therapy.
Mahdieh A; Motasadizadeh H; Maghsoudian S; Sabzevari A; Khalili F; Yeganeh H; Nyström B
Colloids Surf B Biointerfaces; 2024 Apr; 236():113802. PubMed ID: 38382225
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-based nano-formulation with mesoporous silica enhances the anticancer efficacy of phloroglucinol against gastrointestinal cancers.
Shanmugam L; Venkatasubbu GD; Jayaraman M
Int J Biol Macromol; 2024 Apr; 265(Pt 1):130856. PubMed ID: 38490393
[TBL] [Abstract][Full Text] [Related]
15. Injectable, Guest-Host Assembled Polyethylenimine Hydrogel for siRNA Delivery.
Wang LL; Sloand JN; Gaffey AC; Venkataraman CM; Wang Z; Trubelja A; Hammer DA; Atluri P; Burdick JA
Biomacromolecules; 2017 Jan; 18(1):77-86. PubMed ID: 27997133
[TBL] [Abstract][Full Text] [Related]
16. Co-assembly of cisplatin and dasatinib in hyaluronan nanogel to combat triple negative breast cancer with reduced side effects.
Liu R; Hou W; Li J; Gou X; Gao M; Wang H; Zhang Y; Deng H; Yang X; Zhang W
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132074. PubMed ID: 38705320
[TBL] [Abstract][Full Text] [Related]
17. Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an orthotopic ovarian cancer model.
Jones SK; Douglas K; Shields AF; Merkel OM
Biomaterials; 2018 Sep; 178():183-192. PubMed ID: 29935386
[TBL] [Abstract][Full Text] [Related]
18. Novel aromatic moieties-modified poly(glycidyl amine)s with potent siRNA delivery and cancer treatment effect.
Shuai Q; Xie W; Chen S; Su H; Yan Y
J Mater Chem B; 2024 Mar; 12(12):3115-3128. PubMed ID: 38451094
[TBL] [Abstract][Full Text] [Related]
19. Multi-functionalized carbon dots as theranostic nanoagent for gene delivery in lung cancer therapy.
Wu YF; Wu HC; Kuan CH; Lin CJ; Wang LW; Chang CW; Wang TW
Sci Rep; 2016 Feb; 6():21170. PubMed ID: 26880047
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Potentials of Hyaluronic Acid-coated Polymeric Nanoparticles in Enhanced Cancer Treatment by Precision Drug Delivery, Tackling Drug Resistance, and Reshaping the Tumour Micro Environment.
Raval H; Bhattacharya S
Curr Med Chem; 2024 Apr; ():. PubMed ID: 38571347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
